CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 262 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $3,696,000 | -9.4% | 70,000 | +16.7% | 2.43% | -8.5% |
| Q4 2017 | $4,080,000 | -69.1% | 60,000 | -62.5% | 2.66% | -26.9% |
| Q3 2017 | $13,184,000 | +87.8% | 160,000 | +113.3% | 3.64% | -8.4% |
| Q2 2017 | $7,022,000 | +120.5% | 75,000 | +50.0% | 3.97% | +152.1% |
| Q1 2017 | $3,184,000 | -4.4% | 50,000 | -33.3% | 1.58% | -20.9% |
| Q4 2016 | $3,332,000 | -85.8% | 75,000 | -88.5% | 1.99% | -52.3% |
| Q3 2016 | $23,432,000 | +1797.3% | 650,000 | +622.2% | 4.18% | +732.1% |
| Q2 2016 | $1,235,000 | – | 90,000 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
| Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
| Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
| Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
| NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
| Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
| HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
| Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
| Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
| Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |